← Back to Search

Genetic Testing

Genetic Testing for Rare Genetic Disorders (GIVE Trial)

N/A

Recruiting

Led By Seema Lalani

Research Sponsored by Baylor College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

GIVE Trial Summary

This trial is testing a new way to provide care and genomic sequencing to children with rare disorders who live along the Texas-Mexico border, in hopes of improving their genetic health.

Who is the study for?

This trial is for pediatric patients living in the Rio Grande Valley, Texas, who have rare genetic diseases that remain undiagnosed. Children already diagnosed with a known genetic disease cannot participate.Check my eligibility

What is being tested?

The study is testing a web-based model called Consultagene to deliver care and perform Whole Genome Sequencing (WGS) remotely to help identify genetic disorders in children from less resourced areas.See study design

What are the potential side effects?

Since this trial involves genomic sequencing and virtual evaluation rather than medication or invasive procedures, there are no direct physical side effects associated with the interventions being studied.

GIVE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time to diagnosis

GIVE Trial Design

1Treatment groups

Experimental Treatment

Group I: WGS armExperimental Treatment1 Intervention

All 100 patients recruited will undergo WGS

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor

1,001 Previous Clinical Trials

6,002,080 Total Patients Enrolled

Seema LalaniPrincipal InvestigatorBaylor College of Medicine

Media Library

Whole genome sequencing (WGS) (Genetic Testing) Clinical Trial Eligibility Overview. Trial Name: NCT05318222 — N/A

Congenital Anomalies Research Study Groups: WGS arm

Congenital Anomalies Clinical Trial 2023: Whole genome sequencing (WGS) Highlights & Side Effects. Trial Name: NCT05318222 — N/A

Whole genome sequencing (WGS) (Genetic Testing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05318222 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of participants in this experiment?

"Affirmative. Per the information hosted on clinicaltrials.gov, this medical trial went live on February 1st 2022 and is currently in search of 100 participants at a single centre. It was last updated on April 10th 2022."

Answered by AI

Is this experimental program currently welcoming enrollees?

"Clinicaltrials.gov reveals that this clinical trial is currently accepting applications, having been established on February 1st 2022 and last edited April 10th of the same year."

Answered by AI

Does the trial stipulate any age restrictions?

"Eligibility requirements for this trial include patients ranging from 0 days old to 18 years of age. There are 82 trials that cater specifically to those under the legal age and 86 studies focusing on individuals over 65."

Answered by AI

Is participation in this trial open to me?

"To be considered for this research study, applicants must exhibit a neurodevelopmental disorder and have an age ranging from birth to 18 years old. The team aims to enroll approximately 100 patients in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Genetic Inclusion by Virtual Evaluation

Seema Lalani 2022. "Genetic Inclusion by Virtual Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05318222.